The pathogenesis and management of non-alcoholic fatty liver disease coexisted with type 2 diabetes
Liu, Y.; Hong, T.
Zhonghua Yi Xue Za Zhi 95(44): 3565-3567
2015
ISSN/ISBN: 0376-2491 PMID: 26813365 Document Number: 679331
Document emailed within 1 workday
Related Documents
Zhu, Q.-q.; Lou, D.-j.; Si, X.-w.; Guan, L.-l.; You, Q.-y.; Yu, Z.-m.; Zhang, A.-z.; Li, D. 2010: Serum omega-3 polyunsaturated fatty acid and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease Zhonghua Nei Ke Za Zhi 49(4): 305-308Yoshihara, H.; Sato, N.; Kubota, S.; Inoue, A.; Matsumura, T.; Hayashi, N.; Kawano, S.; Kamada, T. 1985: Serum holo and apo type activity of mitochondrial GOT in patients with alcoholic liver disease--with special reference to alcoholic fatty liver Arukoru Kenkyu to Yakubutsu Izon 20(2): 166-174
Jin, H-Bin.; Gu, Z-Ying.; Yu, C-Hui.; Li, Y-Ming. 2005: Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(3): 389-392
Madan, K.; Dhingra, A. 2012: Mortality and non-alcoholic fatty liver disease: type of study cohort matters! National Medical Journal of India 25(1): 28-30
Neeraj; Srivastava, S.; Gole, A.R. 2020: Prevalence of Non Alcoholic Fatty Pancreatic Disease (NAFPD) in General Adult Population and its Association with Type 2 Diabetes Mellitus Journal of the Association of Physicians of India 68(1): 92
Ishii, K.-a.; Takamura, T. 2016: Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition Clinical Calcium 26(3): 363-367
Fukuhara, T.; Hyogo, H.; Ochi, H.; Fujino, H.; Kan, H.; Naeshiro, N.; Honda, Y.; Miyaki, D.; Kawaoka, T.; Tsuge, M.; Hiramatsu, A.; Imamura, M.; Kawakami, Y.; Aikata, H.; Chayama, K. 2014: Efficacy and safety of sitagliptin for the treatment of nonalcoholic fatty liver disease with type 2 diabetes mellitus Hepato-Gastroenterology 61(130): 323-328
Aller, R.; De Luis, D.A.; Fernandez, L.; Calle, F.; Velayos, B.; Izaola, O.; Gonzalez Sagrado, M.; Conde, R.; Gonzalez, J.M. 2009: Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease European Review for Medical and Pharmacological Sciences 13(5): 357-364
Yatsuji, S.; Hashimoto, E. 2006: Natural history of Japanese patients with non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis (NASH) patients with hepatocellular carcinoma (HCC) Nihon Rinsho. Japanese Journal of Clinical Medicine 64(6): 1173-1179
Joos, W.; Mörl, M. 1984: Alcohol-induced organic lesions. 3. Liver damage - alcoholic fatty liver, alcoholic hepatitis, acute and chronic clinical course Fortschritte der Medizin 102(4): 79-82
Dasarathy, J.; Allampati, S.; Alexander, C.; McCullough, A. 2016: Non-alcoholic fatty liver disease: What's in our arsenal? Journal of Family Practice 65(4): 239-244
Sdiri, W.; Romdhane, H.; Mbarek, D.; Ben Abdallah, H.; Longo, S.; Abdelli, M.N.; Boujnah, M.R. 2013: Non alcoholic fatty liver disease: a new risk factor for cardiovascular disease? La Tunisie Medicale 91(3): 171-174
Björklund, J.; Laursen, T.L.; Kazankov, K.; Thomsen, K.L.; Hamilton-Dutoit, S.; Stenbøg, E.; Grønbæk, H. 2017: Non-alcoholic fatty liver disease in children and adolescents Ugeskrift for Laeger 179(27)
Fan, J.-G.; Farrell, G.C. 2009: Epidemiology of non-alcoholic fatty liver disease in China Journal of Hepatology 50(1): 204-210
Lauterburg, B.H. 1992: Pathogenesis of alcoholic liver disease Schweizerische Medizinische Wochenschrift 122(17): 609-613
Abenavoli, L.; Milic, N.; Luigiano, C. 2014: Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver disease Minerva Medica 105(2): 175
Roĭtberg, G.E.; Sharkhun, O.O.; Ushakova, T.I. 2010: Non-alcoholic fatty liver disease as an atherosclerosis risk factor Eksperimental'naia i Klinicheskaia Gastroenterologiia 7: 20-24
Heebøll, S.; Kazankov, K.; Poulsen, M.K.ær.; Vilstrup, H.; Grønbæk, H. 2012: Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis Ugeskrift for Laeger 174(8): 488-490
Shukla, V.; Fatima, J.; Chaudhary, S.; Ali, M.; Mishra, I. 2017: A Study of Endothelial Dysfunction in Patients of Non-Alcoholic Fatty Liver Disease Journal of the Association of Physicians of India 65(9): 18-22
Karoli, R.; Fatima, J.; Singh, P.Shanker.; Siddiqi, Z.; Varshney, S.; Beg, M.Sameer.; Khan, M.Ali. 2019: Association of Genetic Non-alcoholic Fatty Liver Disease with Insulin Resistance-Are we Different? Journal of the Association of Physicians of India 67(3): 34-38